Browse site A to Z

Search results

Search Type: Criteria:

Url: /Media/UHS-website-2019/Docs/Services/Maternity/Combined-PIS-and-Consent-Form-for-Anonymous-Online-Surveys.docx

Description: Auto Generated Title Select from: Links by Category Useful web links A-Z
Url: /Hidden/ChildrensHealthServices/HealthInformation/HealthInformationOnline/InformationByCategory/Consenttotreatment.aspx

Description: Nearly twenty years ago, a court was faced with an agonising decision: whether the proposed separation of conjoined twins was lawful
Url: /HealthProfessionals/Clinical-law-updates/Body-modification.aspx

Description: University Hospital Southampton NHS Foundation Trust PATHOLOGY DIRECTORATE Cellular Pathology (Management) MP 000 028 Revision 24 Page 1 o
Url: /Media/UHS-website-2019/Docs/Services/Pathology/Cell-path/MP000-028-Cellular-pathology-user-handbook-v24.pdf

Description: CONFIDENTIAL ACCORD-2-001 – Master Protocol TITLE PAGE Protocol Title: ACCORD-2: A Multicentre, Seamless, Phase 2 Adaptive Randomisation Platform Study to Assess the Efficacy and Safety of Multiple Candidate Agents for the Treatment of COVID-19 in Hospitalised Patients Master Protocol Number: ACCORD-2-001 Product: Multiple candidate agents Study Phase: 2 Sponsor Name: University Hospital Southampton NHS Foundation Trust Legal Registered Address: Southampton General Hospital Level E, Laboratory & Pathology
Url: /Media/Southampton-Clinical-Research/COVID-19/ACCORD/ACCORD-2-master-protocol.pdf

Description: Southampton NIHR Clinical Research Facility University Hospital Southampton NHS Foundation Trust C Level West Wing, Mai
Url: /Media/Southampton-Clinical-Research/Downloads/VAC31518COV2001-UK-Young-Person-Patient-Information-Sheet-ICF-V2.0-15Feb2021-Clean-Localised-3.pdf

Description: Distinguishing mental disorder from mental incapacity poses a problem for clinicians.
Url: /HealthProfessionals/Clinical-law-updates/Distinguishing-mental-disorder-from-mental-incapacity.aspx

Description: A randomised phase IIb trial of BE AC v izumab added to Temozolomide O ± Irin tecan for children with N refractory/relapsed euroblastoma Version 8.0 dated 07-Mar-2023 Dinutuximab beta amendment Coordinating Sponsor: Sponsor Protocol Number: CAS Code: EudraCT Number: ISRCTN Reference Number: ITCC Number: Roche Study Reference Number: Email: University of Birmingham RG_ 11-087 BN2008 2012-000072-42 40708286 032 MO28245 beacon@trials.bham.ac.uk This application is supported by the facilities funded through Birmingham Science City: Translational Medicine Clinical Rese
Url: /Media/UHS-website-2019/Docs/PaediatricOncology/beacon-protocol-v8.0-07mar2023-signed.pdf

Description: Southampton NIHR Clinical Research Facility University Hospital Southampton NHS Foundation Trust C Level West Win
Url: /Media/Southampton-Clinical-Research/Downloads/VAC31518COV2001-UK-Parent-and-Guardian-ICF-V2.0-15Feb2021-Clean-Localised-1.pdf

Description: PARTICIPANT INFORMATION SHEET Improving Black Health Outcomes (IBHO) NIHR BioResource Version 1.4, 12 Sep 2024 Reading ti
Url: /Media/Southampton-Clinical-Research/Downloads/NIHR-RTB-IBHO-PIS-ICF-v1.4-12SEP2024-Localised.pdf

11 to 20 of 390

Previous 1 2 3 4 5 … Next